Oxford: Millions of Covid-19 vaccine doses ready by year’s end
Today we are reporting on the phase one trial in just over a thousand people of this vaccine designed by oxford university and now partnered with AstraZeneca and the results are good!
We are seeing a good safety profile across a large number of people and very importantly we are seeing strong immune responses.
We all hope it keeps up the good work!!